Cannabis Bioscience International Holdings, Inc. (CBIH) Stock

About Cannabis Bioscience International Holdings, Inc.

China Infrastructure Construction Corp. delivers specialized education focusing on medical cannabis to audiences in the United States and Latin America, while also reaching a global market through its online programs. The company further extends its services to therapeutic areas, including supporting clinical trials and offering focused treatment for sleep disorders, specifically those linked to infertility, all managed through its fertility and sleep center located in Houston, Texas. Its Pharmacology University division broadens this scope by providing consulting, digital publishing, marketing, and franchising opportunities, alongside additional educational content related to medical cannabis. Founded in 2003, the organization's main operational hub is situated in Houston, Texas.

Cannabis Bioscience International Holdings, Inc. (CBIH) stock trades at $0.00 with a market capitalization of $1.74M. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of -1.19, price-to-sales of 14.11. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Cannabis Bioscience International Holdings, Inc. generates a return on equity (ROE) of 100.00% — well above the market average, a sign of a high-quality business, return on capital employed of 31.76%, an operating margin of -832.30%, a net profit margin of 0.00%.

Official website: www.cbih.net